View Published SNOMED CT Subset Metadata

QOF - salicylate antiplatelet medication prescribable in general practice


Subset Name :   
QOF - salicylate antiplatelet medication prescribable in general practice
Subset Original Id :   
633301000001132
Subset Type :   
Realm Concept

Refset FSN :   
Quality and Outcomes Framework general practice extraction - salicylate antiplatelet medication prescribable within general practice simple reference set (foundation metadata concept)
Refset Id :   
12463701000001103
Refset Type :   
Simple

Subset Description :
All VMPs and AMPs associated with the following VTMs: Aspirin, Aspirin + Isosorbide mononitrate and Dipyridamole + Aspirin. The subset also excludes all VMPs and AMPs that have any of the following drug forms: Liquid and Powder and solvent for solution for injection. This subset, as currently published, supports the NHS England QOF business rules for 2016-2017. This subset may contain invalid concepts.

Status

Subset Status :   
Supported
Subset Status Date :   
Mar 30, 2016
Owner (Organisation name) :   
NHS Digital

Purpose and Scope

Usage 1 :

   
Usage Type :    
Intended
Usage Description :    
Intended for secondary uses purposes. Management Information to support counts for establishing Quality and Outcomes Framework points used to determine Practice QOF payments. QOF Indicators Supported: Indicator AF005: In those patients with atrial fibrillation in whom there is a record of a CHADS2 score of 1, the percentage of patients who are currently treated with anti-coagulation drug therapy or anti-platelet therapy Indicator AF005: In those patients with atrial fibrillation in whom there is a record of a CHADS2 score of 1, the percentage of patients who are currently treated with anti-coagulation drug therapy or anti-platelet therapy. Indicator PAD004: The percentage of patients with peripheral arterial disease with a record in the preceding 12 months that aspirin or an alternative anti-platelet is being taken. Indicator STIA007: The percentage of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record in the preceding 12 months that an anti-platelet agent, or an anti-coagulant is being taken. Indicator CHD005: The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken. NICE clinical guidelines & advice: Antiplatelet treatment http://cks.nice.org.uk/antiplatelet-treatment These subsets are created using the XML format dm+d data and so within these subsets a small number of concepts are inactive (status 2 or 10) in the International Release. The origin of these inactive concepts is the native XML dm+d and they are now inactive in the new International Release due to natural movement and updating of the International Release content. Work is underway to update the dm+d concepts to the new International release identifiers; at this point this mismatch will be resolved. If using the dm+d in SNOMED CT format the International Release relationships will enable migration to the replacement concept. The subsets as published in the current release data are applicable to the QOF year 2016-2017.
Geographic Usage :    
England
Usage Category:    
 Quality Outcome Framework Prescribable


Scope :

   
Inclusion Criteria :   
Age group - any age; Gender - not specified; Sex - not specified
Subject Category :   
Prescribing; Chemicals and Drugs

Publication

Subset Release Category :   
UK Drug Extension
Language :   
en
Folder Name :   
QOF
File Name :   
der1_SubsetMembers_QOFSalicylateAntiMedPresGenPract_GB1000001_YYYYMMDD

Subset Licence Type :   
IHTSDO SNOMED CT® Licence; UKTC SNOMED CT® Licence; Open Government Licence

Metadata Version :   
7.0
Last Updated :   
Feb 14, 2018

Related Links

Subset download with descriptions :

UK Drug Extension releases